Singapore Medical Group's potential share transaction with third party to be dropped
Add BT as a preferred sourceSINGAPORE Medical Group (SMG) announced that a potential transaction involving its company's shares will not be explored further, according to an exchange filing on Thursday.
In December last year, the group said that it was in preliminary discussions with a third party regarding a transaction involving SMG's shares. This was shared in response to a query from its sponsor CIMB Bank Singapore regarding "unusual price movements" and the significant volume of trading in the shares.
In the filing, SMG said that it remains open to exploring various avenues to improve shareholder value, including corporate actions.
As at 9.35am on Thursday, SMG shares were trading at 31 Singapore cents, down 3.5 cents or 10.1 per cent.
Decoding Asia newsletter: your guide to navigating Asia in a new global order. Sign up here to get Decoding Asia newsletter. Delivered to your inbox. Free.
Share with us your feedback on BT's products and services
TRENDING NOW
Not in education, employment or training: Why more Hong Kong youths are opting out of work
Taiwan’s wealthy seeks diversification to Singapore, sparking private banking race: Bloomberg
Malaysian tycoon Vincent Tan’s sell-downs point to pruning rather than an exit plan
Palm oil stocks set to surge as Indonesia said to be scaling back export overhaul: analysts
